The Consensus Council serves as the consensus body for CLSI. It assesses and prioritizes projects based on medical utility, clinical relevance, and CLSI’s mission.
Leadership
Our Leadership is driven by the highest standards.
“Whether it’s the development of clinical standards or the delivery of rigorous education, training, and webinars, our work ensures the integrity and reliability of the tests that inform diagnosis. With our help, every patient begins the journey knowing their path has been built on the strongest of foundations.”
Board of Directors
Active Advocates
for CLSI and its Vision
With balanced representation from government, industry, and the health care professions, the CLSI Board of Directors is dedicated to maintaining the integrity of the voluntary consensus process, promoting quality medical testing and health care services, and fulfilling the CLSI mission.
Officers of the Board
CLSI Board of Directors
Lorin Bachmann, PhD, DABCC, MT(ASCP)
Leonthena (Lea) R. Carrington, MBA, MS, MT(ASCP)
Collette Fitzgerald, PhD
Randall T. Hayden, MD
Debbie Kuehl
Loralie J. Langman, PhD, DABCC, FACB, F-ABFT
Tania Motschman, MS, MT(ASCP)SBB
Zahra Shajani-Yi, PhD, DABCC, FADLM
Barbara L. Zimmer, PhD
2024 Consensus Council
Stewardship for
the Consensus Process
- Deirdre Astin, MS | Member | New York State Department of Health, United States
- Victor R. De Jesus, PhD | Member | Centers for Disease Control and Prevention, United States
- Jamie Phillips Deeter, PhD, MS | Member | Roche Diagnostics, United States
- Kristen Meier, PhD | Member | Data Fi, LLC, United States
- Tania Motschman, MS, MT(ASCP)SBB | Chairholder, United States
- Paulo Pereira, PhD | Member | Portuguese Institute of Blood and Transplantation, Portugal
- Victoria Petrides, MS | Vice-Chairholder | Abbott Laboratories, United States
- Ribhi M. Shawar, PhD, D(ABMM), F(AAM) | Member | FDA Center for Devices and Radiological Health, United States
- Matthew A. Wikler, MD, FIDSA, MBA | Emeritus Member | IDTD Consulting, United States
- Barbara Zehnbauer, PhD | Member | Emory University Hospital, United States
LDT Advisory Group
LDT Advisory Group
The LDT Advisory Group was formed to provide CLSI with additional subject-matter expertise and advice on the FDA LDT Final Rule regulatory requirements and laboratory implementation to assist with and to support CLSI’s organizational response to the FDA LDT Final Ruling (May 2024).
- Shannon Bennett, MS, MBA, CMQOE(ASQ) | Member | Mayo Clinic, United States
- Sara Blosser, PhD, D(ABMM) | Member | Centers for Disease Control and Prevention , United States
- Margot Borgel, PhD | Member | RQM+, United States
- Robert F. Klees, PhD | Member | New York State Dept. of Health, United States
- Varvara Kozyreva, PhD, HCLD(ABB) | Member | California Department of Public Health, United States
- Sonia La'ulu, MBA,BS | Member | ARUP Laboratories, United States
- Kenneth Lewis | Member | HCA Healthcare , United States
- Dun Liang, PhD | Member | Eli Lilly, United States
- Melinda B. Nye, PhD, MT(ASCP) | Member | Lab Corp of America, United States
- A. Joe Saad, MD | Member | Methodist Dallas Medical Center , United States
- Kileen Shier, PhD, MBA | Member | Quest Diagnostics, United States
- Melanie Sloan | Member | AABB, United States
- Scott Thiel | Member | Hologic, Inc., United States
- Mario Wijker | Member | Bio-Rad, Netherlands
- Marisa Winkler, PhD, MD | Member | JMI Laboratories, United States
History
Founded in 1967, CLSI has been the global authority for international clinical and laboratory standards, cultivating best practices and fostering innovation through standards development, education, and training.
Excellence Awards
CLSI Excellence Awards recognize the achievements of CLSI volunteers and organizational members who are committed to CLSI’s mission and have helped improve the quality of medical care worldwide.